• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Investments

Growth funding: is it all downhill from here?

Growth investments decline heavily in Q3
  • Anneken Tappe
  • 07 December 2011
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Expansion and early-stage deal numbers declined steadily in Q3 2011, leaving the industry expecting a grim final quarter of the year. Anneken Tappe reports

Over the past six years, unquote" data shows three significant peaks in expansion and early-stage deal volume across Europe: deals rose significantly in late 2006 and showed an increase to a record high in Q1 of 2008. The third peak, between Q1 and Q2 of 2010, was followed by a slump, potentially caused by the lacklustre pace of economic recovery. Since then, growth deals have been on a steady decline, falling to less than half that seen in 2006.

 Volume of expansion and early-stage deals in Europe

The decline in 2011 suggests an equally slow, if not even slower final quarter of the year and overshadows hopes for a more fruitful 2012. At the same time, each first quarter over the past five years, with the exception of 2009, has seen a slight increase of deal volume. These contrasting indicators make it very difficult to predict how growth funding will develop in the New Year.

"There are longer term factors in addition to the immediate market environment, like, for example, access to institutional fundraising, which has been difficult since the dot-com bubble burst," says ECVA's Ross Butler.

The current decline is even more visible when figures for expansions and early-stage activity are separated. While early-stage investments closely follow market trends, expansions do not follow the overall data whatsoever. After a significant hike that started in late 2007, expansion acitivity peaked in 2010 but has failed to impress ever since.

Volume of expansion and early-stage deals in Europe

The fallout of the financial crisis could be responsible for the short-lived revival in deal numbers. "Growth capital was in vogue after the first credit crunch, because people had money to put to work, but credit was difficult," Butler saysEVCA's own Quarterly Activity Indicator shows venture capital investments decreased by 11% between Q2 and Q3 of 2011, providing further evidence of the uncertainty that is dominating the market.

But EVCA pleads caution: "Venture capital is a fairly long term asset class, so there is only so much you can read into quarterly results."

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Investments
  • UK / Ireland
  • Southern Europe
  • Benelux
  • Nordics
  • France
  • DACH
  • EVCA
  • Unquote Data

More on Investments

EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
Jan Cerny of BHM Group
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • Investments
  • 01 September 2023
Reima Linnanvirta of Trind VC
Trind VC plans up to five early-stage investments in next six months

VC has deployed around 10% of its second, EUR 55m fund and plans to invest in up to 40 startups

  • Venture
  • 31 August 2023
Guillaume Fournier of Credo Ventures
Credo Ventures sees activity uptick, plans further deals in 2023 with EUR 75m fourth fund

Czech VC firm's latest vehicle is around 50% deployed and expects to make 25-30 deals in total

  • Venture
  • 23 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013